Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the accuracy of the WaveLight FS200 femtosecond laser, as assessed by 1 day and 1 month post-operative optical coherence tomography (OCT) anterior segment corneal measurements compared to pre-operative flap thickness target.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| WaveLight Refractive Suite | Experimental | LASIK surgery (laser in situ keratomileusis) per standard of care |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| WaveLight® Refractive Suite | Device | Excimer EX500 and Femtosecond FS200 lasers (Wavelight® Refractive Suite) used during LASIK surgery for corneal flap creation and corneal ablation |
| Measure | Description | Time Frame |
|---|---|---|
| The Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operatively | The expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness at Day 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness. | Day 1 Postoperative |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of Development of Opaque Bubble Layer (OBL) | OBL (the collection of gas bubbles during corneal flap creation) was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of participants with opaque bubble layer development during femtosecond flap creation. | Operation/Surgery (Day 1) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sr. Clinical Manager, GCRA, Global Med Affairs, Operations | Alcon Research | Study Director |
Not provided
Of the 60 enrolled subjects, 1 was exited as a screen failure prior to surgery. This reporting group includes all enrolled subjects who underwent LASIK surgery (59).
Subjects were recruited from 1 study center located in the US and 1 study center located in Greece.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | WaveLight Refractive Suite | Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
This analysis population includes all enrolled subjects who underwent LASIK surgery (59).
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | WaveLight Refractive Suite | Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | The Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operatively | The expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness at Day 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | microns | Day 1 Postoperative |
|
Adverse events (AEs) were collected for the duration of a subject's participation in the study (up to 12 months). This reporting group includes all enrolled subjects who underwent LASIK surgery.
An AE was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in subjects, users or other persons, whether or not related to the medical device.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | WaveLight Refractive Suite | Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Global Brand Med Affairs Lead, Refractive, VGR | Alcon Research, Ltd. | 1-888-451-3937 | alcon.medinfo@alcon.com |
| ID | Term |
|---|---|
| D012030 | Refractive Errors |
| D009216 | Myopia |
| D001251 | Astigmatism |
| ID | Term |
|---|---|
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| LASIK surgery | Procedure | Surgical procedure for treating refractive error based on corneal reshaping |
|
| Extent of Opaque Bubble Layer (OBL) Within the Femtosecond Flap |
The extent of OBL was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of flap with opaque bubble layer development during femtosecond flap creation. |
| Operation/Surgery (Day 1) |
| The Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined Preoperatively | The expected flap thickness as determined pre-operatively subtracted from the achieved flap thickness at Month 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness. | Month 1 Postoperative |
| Uncorrected Visual Acuity (UCVA) | Visual acuity (VA) without spectacles or other visual corrective devices, was performed with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart set at a distance of 4 meters. UCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity. | Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Best Corrected Visual Acuity (BCVA) | VA with the subjects's best spectacles or other visual corrective devices, was performed with an ETDRS chart set at a distance of 4 meters. BCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity. | Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Manifest Refraction (Sphere) | A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis. | Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Manifest Refraction (Cylinder) | A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis. | Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Mean Contrast Sensitivity (CS) | Contrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity. Both eyes contributed to the analysis. | Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Corneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT) | The diameter of the corneal flap was assessed by OCT (ie. an imaging method using light to capture three-dimensional images). Corneal flap is measured in millimeters. | Operation/Surgery (Day 1), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Wavefront Aberrometry | Wavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trefoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology. | Operation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Mean Response: "Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses" | As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision). | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Percent Response to "Have Always Worn Glasses or Contact Lenses in the Past 4 Weeks" | As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error. | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Percent Response by Category: "I Worry About my Vision" | As recorded by the subject on the RSVP questionnaire | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Percent Response by Category: "My Vision is a Concern in my Daily Life" | As recorded by the subject on the RSVP questionnaire | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Percent Response by Category: "Driving at Night" | As recorded by the subject on the RSVP questionnaire, where 0 is "Not applicable", 1 is "No difficulty at all", 2 is "A little difficulty", 3 is "Moderate difficulty", 4 is "Severe difficulty" and 5 is "So much difficulty that I did not do the activity with this alternative". | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Corneal Curvature as Measured by Keratometry | Corneal curvature as assessed by a commercially available system and measured in diopters. | Baseline/Screening (Day 0), 1 Month Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Flap Creation Time as Documented in the Log Files | The time to create the flap with FS200 Femtosecond Flap Creation System, measured in seconds. | Operation/Surgery (Day 1) |
| Corneal Topography: Q-value | The Q-value (a measure of corneal asphericity) was assessed using a commercially available system. The Q-values are negative (-1 < Q < 0) for prolate corneas, in which the central curvature is steeper than the peripheral curvature, and positive (Q > 0) for oblate corneas, in which the central curvature is flatter than the peripheral curvature. | Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Corneal Topography: Anterior Chamber (AC) Volume | The AC volume (a measure of the shallowness of the anterior chamber) was assessed using a commercially available system. The lower the chamber volume, the more shallow the anterior chamber or the chamber angle. | Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Corneal Topography: Anterior Chamber (AC) Depth | The AC depth (axial distance between the anterior surface of the cornea and the anterior surface of the lens) was assessed using a commercially available system. A higher value represents a longer distance. | Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| Corneal Topography: Angles | The angles (angular measurement of the space between the iris and the lens) were assessed using a commercially available system. The higher the value, the bigger the space. | Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
| years |
|
| Gender | Count of Participants | Participants |
|
|
|
| Secondary | Incidence of Development of Opaque Bubble Layer (OBL) | OBL (the collection of gas bubbles during corneal flap creation) was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of participants with opaque bubble layer development during femtosecond flap creation. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Number | percentage of participants | Operation/Surgery (Day 1) |
|
|
|
| Secondary | Extent of Opaque Bubble Layer (OBL) Within the Femtosecond Flap | The extent of OBL was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of flap with opaque bubble layer development during femtosecond flap creation. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | percentage of flap | Operation/Surgery (Day 1) |
|
|
|
| Secondary | The Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined Preoperatively | The expected flap thickness as determined pre-operatively subtracted from the achieved flap thickness at Month 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness. | This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point. | Posted | Mean | Standard Deviation | microns | Month 1 Postoperative |
|
|
|
| Secondary | Uncorrected Visual Acuity (UCVA) | Visual acuity (VA) without spectacles or other visual corrective devices, was performed with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart set at a distance of 4 meters. UCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | logMAR | Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Best Corrected Visual Acuity (BCVA) | VA with the subjects's best spectacles or other visual corrective devices, was performed with an ETDRS chart set at a distance of 4 meters. BCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | logMAR | Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Manifest Refraction (Sphere) | A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | Diopters | Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative | Eyes | Eyes |
|
|
|
| Secondary | Manifest Refraction (Cylinder) | A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | Diopters | Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative | eyes | eyes |
|
|
|
| Secondary | Mean Contrast Sensitivity (CS) | Contrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity. Both eyes contributed to the analysis. | This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point. | Posted | Mean | Standard Deviation | logCS | Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Corneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT) | The diameter of the corneal flap was assessed by OCT (ie. an imaging method using light to capture three-dimensional images). Corneal flap is measured in millimeters. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | millimeters | Operation/Surgery (Day 1), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Wavefront Aberrometry | Wavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trefoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology. | This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point. | Posted | Mean | Standard Deviation | micrometers | Operation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Mean Response: "Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses" | As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision). | This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point. | Posted | Mean | Standard Deviation | units on a scale | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Percent Response to "Have Always Worn Glasses or Contact Lenses in the Past 4 Weeks" | As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error. | This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint. | Posted | Number | percentage of subjects | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Percent Response by Category: "I Worry About my Vision" | As recorded by the subject on the RSVP questionnaire | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Number | percentage of subjects | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Percent Response by Category: "My Vision is a Concern in my Daily Life" | As recorded by the subject on the RSVP questionnaire | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Number | percentage of subjects | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Percent Response by Category: "Driving at Night" | As recorded by the subject on the RSVP questionnaire, where 0 is "Not applicable", 1 is "No difficulty at all", 2 is "A little difficulty", 3 is "Moderate difficulty", 4 is "Severe difficulty" and 5 is "So much difficulty that I did not do the activity with this alternative". | This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point. | Posted | Number | percentage of subjects | Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Corneal Curvature as Measured by Keratometry | Corneal curvature as assessed by a commercially available system and measured in diopters. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | diopter | Baseline/Screening (Day 0), 1 Month Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative |
|
|
|
| Secondary | Flap Creation Time as Documented in the Log Files | The time to create the flap with FS200 Femtosecond Flap Creation System, measured in seconds. | This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint. | Posted | Mean | Standard Deviation | seconds | Operation/Surgery (Day 1) |
|
|
|
| Secondary | Corneal Topography: Q-value | The Q-value (a measure of corneal asphericity) was assessed using a commercially available system. The Q-values are negative (-1 < Q < 0) for prolate corneas, in which the central curvature is steeper than the peripheral curvature, and positive (Q > 0) for oblate corneas, in which the central curvature is flatter than the peripheral curvature. | This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, "n" includes all eyes with data. | Posted | Mean | Standard Deviation | unit less | Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative | Eyes | Eyes |
|
|
|
| Secondary | Corneal Topography: Anterior Chamber (AC) Volume | The AC volume (a measure of the shallowness of the anterior chamber) was assessed using a commercially available system. The lower the chamber volume, the more shallow the anterior chamber or the chamber angle. | This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, "n" includes all eyes with data. | Posted | Mean | Standard Deviation | millimeters cubed | Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative | Eyes | Eyes |
|
|
|
| Secondary | Corneal Topography: Anterior Chamber (AC) Depth | The AC depth (axial distance between the anterior surface of the cornea and the anterior surface of the lens) was assessed using a commercially available system. A higher value represents a longer distance. | This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, "n" includes all eyes with data. | Posted | Mean | Standard Deviation | millimeters | Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative | Eyes | Eyes |
|
|
|
| Secondary | Corneal Topography: Angles | The angles (angular measurement of the space between the iris and the lens) were assessed using a commercially available system. The higher the value, the bigger the space. | This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, "n" includes all eyes with data. | Posted | Mean | Standard Deviation | degrees | Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative | Eyes | Eyes |
|
|
|
| 0 |
| 59 |
| 0 |
| 59 |
Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
| Left eye (OS) |
|
| Both eyes (OU) |
|
| Left eye (OS) |
|
| Both eyes (OU) |
|
| Title | Measurements |
|---|---|
|
| Month 3 Postoperative |
|
| Month 6 Postoperative |
|
| Month 12 Postoperative |
|
| Title | Measurements |
|---|---|
|
| Month 6 Postoperative |
|
| Month 12 Postoperative |
|
| CS B (uncorrected), n=30, 59, 59, 59, 59 |
|
| CS C (uncorrected), n=28, 59, 58, 59, 58 |
|
| CS D (uncorrected), n=29, 58, 57, 56, 58 |
|
| CS A (corrected), n=59, 59, 59, 59, 59 |
|
| CS B (corrected), n=59, 59, 59, 59, 59 |
|
| CS C (corrected), n=59, 59, 58, 59, 58 |
|
| CS C (corrected), n=57, 58, 57, 56, 58 |
|
| Left eye (OS) |
|
| Total Higher Order RMS, Left eye |
|
| Spherical Aberration, Right Eye |
|
| Spherical Aberration, Left Eye |
|
| Coma, Right Eye |
|
| Coma, Left Eye |
|
| Trefoil, Right Eye |
|
| Trefoil, Left Eye |
|
| Yes |
|
| Rarely |
|
| Sometimes |
|
| Often |
|
| Always |
|
| Rarely |
|
| Sometimes |
|
| Often |
|
| Always |
|
| With glasses, 1 |
|
| With glasses, 2 |
|
| With glasses, 3 |
|
| With glasses, 4 |
|
| With glasses, 5 |
|
| With contact lenses, 0 |
|
| With contact lenses, 1 |
|
| With contact lenses, 2 |
|
| With contact lenses, 3 |
|
| With contact lenses, 4 |
|
| With contact lenses, 5 |
|
| Without glasses/contact lenses, 0 |
|
| Without glasses/contact lenses, 1 |
|
| Without glasses/contact lenses, 2 |
|
| Without glasses/contact lenses, 3 |
|
| Without glasses/contact lenses, 4 |
|
| Without glasses/contact lenses, 5 |
|
| K1, Left Eye |
|
| K2, Right Eye |
|
| K2, Left Eye |
|
| Mean K1 and K2, Right Eye |
|
| Mean K1 and K2, Left Eye |
|
| Title | Measurements |
|---|---|
|
| Month 6 Postoperative, n=118 |
|
| Month 12 Postoperative, n=118 |
|
|
| Month 6 Postoperative, n=118 |
|
| Month 12 Postoperative, n=118 |
|
| Title | Measurements |
|---|---|
|
| Month 6 Postoperative, n=118 |
|
| Month 12 Postoperative, n=118 |
|
| Title | Measurements |
|---|---|
|
| Month 6 Postoperative, n=118 |
|
| Month 12 Postoperative, n=118 |
|